Big Pharma Fails 50% of the Time in Phase Three. AI Can Fix That | Vin Singh, BullFrog AI
About this episode
Vin Singh discusses how BullFrog AI aims to improve drug development success rates using advanced AI technology.
It costs up to $2 billion and fifteen years to develop a drug, and big pharma still fails half the time at the final stage. BullFrog AI founder, Chairman, and CEO Vin Singh joins Craig Smith with a clear diagnosis of why: the industry keeps picking the wrong drug target from the beginning, and no amount of downstream optimization fixes a fundamentally wrong starting point. Built on AI technology originally developed at Johns Hopkins' Applied Physics Lab, BullFrog has assembled a three-stage platform that cleans messy clinical data, runs causal analysis to map disease pathways, and then ranks competing drug targets using a competitive framework that removes the subjectivity most pharmaceutical decision-making still relies on. The most striking results in this conversation come from two case studies: work with the Lieber Institute for Brain Development - analyzing thousands of post-mortem brains - that led to the identification of potential driver genes for depression, bipolar disorder, and schizophrenia in months from data that researchers had spent fifteen years studying, and a pancreatic cancer trial where BullFrog's platform identified a patient subgroup with survival rates…
More episodes of Eye On A.I.
- "According to NASA's Definition of Life, I'm Not Alive" - Why Nobody Can Define Life | Dr. Kate Adamala
- 6 in 10 Enterprises Can't Find the Root Cause When Their AI Workloads Fail | Paul Appleby, Virtana
- Inside the Enterprise Browser Rebuilding Security for the AI Era | Bradon Rogers, Island
- What Industrial AI Actually Looks Like | Kriti Sharma, Nexus Black
- The Biggest AI Security Problem Isn't the Model. It's This. | Devvret Rishi
- AI Agents Are Failing and It's Almost Never the Model's Fault | Alberto Pan, Denodo
Explore listener stats, chart rankings, contacts and more on the Eye On A.I. podcast page.